Related Experiment Videos
Genetic polymorphisms of MDM2, cumulative cigarette smoking and nonsmall cell lung cancer risk
Geoffrey Liu1, Paul Wheatley-Price, Wei Zhou
1Applied Molecular Oncology/Department of Medicine, Ontario Cancer Institute/Princess Margaret Hospital, University of Toronto, Toronto, ON, Canada. geoffrey.liu@uhn.on.ca
Abstract:
Abnormalities of the tumor suppressor TP53 pathway are critical in the development of many cancers since it regulates cell cycle components and apoptosis. Murine double minute-2 (MDM2) protein is a central node in the p53 pathway and a direct negative regulator of p53. The MDM2 SNP309 (rs2279744) polymorphism increases MDM2 RNA and protein levels, attenuating the p53 pathway. The MDM2 SNP309 polymorphism was investigated in 1,787 Caucasian nonsmall cell lung cancer (NSCLC) patients and 1,360 healthy controls. Cases and controls were analyzed for associations with genotype and adjusted for age, gender, histology and smoking history. There were no overall associations between the MDM2 genotypes and risk of lung cancer (adjusted odds ratios [AORs] = 0.82 [95% confidence interval [CI] = 0.6-1.1] for the T/G genotype and AOR = 1.32 [95% CI = 0.9-2.0] for the G/G genotype). A statistically significant interaction (p = 0.01) was found between smoking and MDM2 genotypes. Consistent with this interaction, stratified analysis by pack-years of smoking demonstrated that the AORs of G/G vs. T/T were 1.56 (1.0-2.7), 1.46 (1.0-2.2), 0.80 (0.5-1.3) and 0.63 (0.4-1.1), respectively, for never, mild (<30 pack-years), moderate (30-57 pack-years) and heavy smokers (>or=58 pack-years). In conclusion, a strong gene-smoking interaction was observed between the MDM2 SNP309 and NSCLC risk.
Insights
The MDM2 SNP309 gene variant does not directly increase lung cancer risk. However, it significantly interacts with smoking habits, altering cancer risk based on smoking intensity.
Area of Science:
- Oncology
- Genetics
- Molecular Biology
Background:
- The tumor suppressor TP53 pathway is crucial for cancer development, regulating cell cycle and apoptosis.
- Murine double minute-2 (MDM2) protein negatively regulates p53, a key tumor suppressor.
- The MDM2 SNP309 polymorphism elevates MDM2 levels, potentially weakening the p53 pathway.
Purpose of the Study:
- To investigate the association between the MDM2 SNP309 polymorphism and nonsmall cell lung cancer (NSCLC) risk in Caucasians.
- To explore potential interactions between MDM2 genotypes and smoking history in relation to NSCLC risk.
Main Methods:
- A case-control study involving 1,787 NSCLC patients and 1,360 healthy controls.
- Genotyping for MDM2 SNP309 (rs2279744) was performed.
- Statistical analyses adjusted for age, gender, histology, and smoking history, including pack-years.
Main Results:
- No overall association was found between MDM2 genotypes and NSCLC risk.
- A significant interaction (p=0.01) was observed between MDM2 genotypes and smoking.
- Stratified analysis revealed that the G/G genotype increased lung cancer risk in never and light smokers but decreased it in moderate and heavy smokers compared to T/T.
Conclusions:
- The MDM2 SNP309 polymorphism alone does not appear to influence NSCLC risk.
- A significant gene-smoking interaction exists, where the risk associated with MDM2 SNP309 varies considerably with smoking pack-years.
Related Concept Videos
Abnormal Proliferation
Cancer Prevention
Some...
Mismatch Repair
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
Statistical Methods for Analyzing Epidemiological Data
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase